Search
21/07/2023
Opening Treatment Windows for Treatment-Resistant Schizophrenia: Improving Emotion Regulation Strategies Using the Unified Protocol in a Case Study in Spain
Grasa E., Corripio I., Peris-Baquero O., Roldán A., Selma J., Osma J.. Opening Treatment Windows for Treatment-Resistant Schizophrenia: Improving Emotion Regulation Strategies Using the Unified Protocol in a Case Study in Spain. Clinical Case Studies. 2023; DOI:10.1177/15346501231190912. PMID:. IF:0.800(Q4/9D).
20/07/2023
A Novel ELISA for the Quantification of Serum Levels of 2 Glycosylated Variants of Apolipoprotein J: Biomarkers for Myocardial Ischemia
Encinas, LF, Lluch, N, Wu, AHB, Kaski, JC, Badimon, L, Cubedo, J. A Novel ELISA for the Quantification of Serum Levels of 2 Glycosylated Variants of Apolipoprotein J: Biomarkers for Myocardial Ischemia. Journal Of Applied Laboratory Medicine. 2023; 8(5)DOI:10.1093/jalm/jfad034. PMID:37473435. IF:(Q/D).
19/07/2023
Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial
Guan, YF, Puenpatom, A, Johnson, MG, Zhang, Y, Zhao, YJ, Surber, J, Weinberg, A, Brotons, C, Kozlov, R, Lopez, R, Coetzee, K, Santiaguel, J, Du, JJ, Williams-Diaz, A, Brown, M, Paschke, A, De Anda, C, Norquist, JM. Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial. CLINICAL INFECTIOUS DISEASES. 2023; 77(11)DOI:10.1093/cid/ciad409. PMID:37466374. IF:8.200(Q1/1D).
18/07/2023
Exposure to secondhand and thirdhand smoke in private vehicles: Measurements in air and dust samples
Continente X., Henderson E., López-González L., Fernández E., Tigova O., Semple S., O'Donnell R., Navas-Acién A., Cortés-Francisco N., Ramírez N., Dobson R., López M.J., Castellano Y., Fu M., Ballbè M., Amalia B., Arechavala T., Gallus S., Lugo A., Liu X., Borroni E., Stival C., Colombo P., Clancy L., Keogan S., Byrne H., Behrakis P., Tzortzi A., Vardavas C., Vyzikidou V.K., Bakelas G., Mattiampa G., Boffi R., Ruprecht A., De Marco C., Borgini A., Veronese C., Bertoldi M., Tittarelli A., Gorini G., Carreras G., Cortini B., Verdi S., Lachi A., Chellini E., López Nicolás Á., Trapero-Bertran M., Celdrán Guerrero D., Radu-Loghin C., Nguyen D., Starchenko P., Soriano J.B., Ancochea J., Alonso T., Pastor M.T., Erro M., Roca A., Pérez P., Castillo E.G.. Exposure to secondhand and thirdhand smoke in private vehicles: Measurements in air and dust samples. ENVIRONMENTAL RESEARCH. 2023; 235DOI:10.1016/j.envres.2023.116681. PMID:37474087. IF:7.700(Q1/1D).
18/07/2023
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease
Bergami, M, Manfrini, O, Nava, S, Caramori, G, Yoon, J, Badimon, L, Cenko, E, David, A, Demiri, I, Dorobantu, M, Fabin, N, Gheorghe-Fronea, O, Jankovic, R, Kedev, S, Ladjevic, N, Lasica, R, Loncar, G, Mancuso, G, Mendieta, G, Milicic, D, Mjehovic, P, Pasalic, M, Petrovic, M, Poposka, L, Scarpone, M, Stefanovic, M, van der Schaar, M, Vasiljevic, Z, Vavlukis, M, Pittao, MLV, Vukomanovic, V, Zdravkovic, M, Bugiardini, R. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease. Journal of the American Heart Association. 2023; 12(14)DOI:10.1161/JAHA.122.028939. PMID:37449568. IF:5.000(Q1/2D).
17/07/2023
Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review
Olszewska, DA, Shetty, A, Rajalingam, R, Rodriguez-Antiguedad, J, Hamed, M, Huang, JA, Breza, M, Rasheed, A, Bahr, N, Madoev, H, Westenberger, A, Trinh, J, Lohmann, K, Klein, C, Marras, C, Waln, O. Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(10)DOI:10.1111/ene.15969. PMID:37422902. IF:4.500(Q1/2D).
17/07/2023
Physiological responses and behavioural organization of very low birth weight infants during swaddled versus traditional weighing
Vicente-Perez S., Robleda G., Gich I., Nolla T., Ponce-Taylor J., Verd S., Ginovart G.. Physiological responses and behavioural organization of very low birth weight infants during swaddled versus traditional weighing. Nursing Open. 2023; 10(10)DOI:10.1002/nop2.1943. PMID:37458256. IF:2.000(Q2/4D).
15/07/2023
Gender inequalities in the prevalence of low mood and related factors in schooled adolescents during the 2019-2020 school year: DESKcohort project
Gonzalez-Casals, H, Vives, J, Bosque-Prous, M, Folch, C, Drou-Roget, G, Muntaner, C, Vives-Cases, C, Barbaglia, MG, Colom, J, Espelt, A. Gender inequalities in the prevalence of low mood and related factors in schooled adolescents during the 2019-2020 school year: DESKcohort project. JOURNAL OF AFFECTIVE DISORDERS. 2023; 333DOI:10.1016/j.jad.2023.04.058. PMID:37084966. IF:4.900(Q1/2D).
14/07/2023
Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia
Giménez-Pérez G., Vinals, C, Mata-Cases M., Vlacho B., Real J., Franch-Nadal J., Ortega E., Mauricio D.. Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia. Cardiovascular Diabetology. 2023; 22(1)DOI:10.1186/s12933-023-01917-1. PMID:37452416. IF:8.500(Q1/1D).
12/07/2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population
Sahuquillo-Torralba A., Hospital-Gil M., Vilarrasa-Rull E., Llamas-Velasco M., Rivera R., Carrascosa J.M., de la Cueva-Dovao P., Armesto-Santos S., Ruíz-Villaverde R., Velasco-Pastor M., Magdaleno-Tapial J., Yanguas-Bayona J.I., Ribera-Pibernat M., Salgado-Boquete L., Herranz-Pinto P., Romero-Mate A., Martínez-Lorenzo E., López-Estebaranz J.L., Ballescá-López F., Botella-Estrada R.. Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2023; DOI:10.1111/ajd.14130. PMID:37435962. IF:2.200(Q2/5D).
07/07/2023
Piloting the informed health choices resources in Barcelona primary schools: A mixed methods study
Jofra, LS, Alonso-Coello, P, Martinez, EC, Marsal, CD, Iborra, AG, Quispe, EPND, Perez-Gaxiola, G, Requeijo, C, Figuls, MRI, Rosenbaum, S, Salas-Gama, K, Urreta-Barallobre, I, Garcia, LM. Piloting the informed health choices resources in Barcelona primary schools: A mixed methods study. PLoS One. 2023; 18(7)DOI:10.1371/journal.pone.0288082. PMID:37418372. IF:2.900(Q1/3D).
07/07/2023
Social inequalities in self-perceived health in Chile, does the urban environment matter?: a cross-sectional study
López-Contreras N., Puig-Barrachina V., Vives A., Olave-Müller P., Gotsens M.. Social inequalities in self-perceived health in Chile, does the urban environment matter?: a cross-sectional study. Archives of Public Health. 2023; 81(1)DOI:10.1186/s13690-023-01136-w. PMID:37420299. IF:3.200(Q2/3D).
07/07/2023
Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction
Ni, MK, Li, YH, Wei, JH, Song, ZP, Wang, H, Yao, JJ, Chen, YX, Belke, D, Estillore, JP, Wang, RW, Vallmitjana, A, Benitez, R, Hove-Madsen, L, Feng, W, Chen, J, Roston, TM, Sanatani, S, Lehman, A, Chen, SRW. Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction. CIRCULATION RESEARCH. 2023; 133(2)DOI:10.1161/CIRCRESAHA.123.322504. PMID:37325910. IF:16.500(Q1/1D).
06/07/2023
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
Revilla, G, Ruiz-Auladell, L, Vallverdu, NF, Santamaria, P, Moral, A, Perez, JI, Li, CD, Fuste, V, Lerma, E, Corcoy, R, Pitoia, F, Escola-Gil, JC, Mato, E. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241311153. PMID:37446330. IF:4.900(Q1/3D).
06/07/2023
Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundacio Puigvert's Experience
Baboudjian M., Territo A., Gallioli A., Verri P., Aumatell J., Izquierdo P., Uleri A., Tedde A., Basile G., Gaya J.M., Huguet J., Rodriguez-Faba O., Sanguedolce F., Algaba F., Palou J., Breda A.. Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundacio Puigvert's Experience. JOURNAL OF ENDOUROLOGY. 2023; 37(9)DOI:10.1089/end.2023.0092. PMID:37310884. IF:2.900(Q1/3D).
06/07/2023
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center
Arguello-Tomas M., Albiol N., Jara P., Garcia-Cadenas I., Redondo S., Esquirol A., Novelli S., Saavedra S., Martino R., Nomdedeu J., Sierra J., Mora A., Moreno C.. Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center. LEUKEMIA & LYMPHOMA. 2023; 64(10)DOI:10.1080/10428194.2023.2232489. PMID:37452739. IF:2.200(Q3/6D).
05/07/2023
Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report
Martinez-Horta, S, Marzal-Espi, CN, Cuso-Garcia, S, Aracil-Bolanos, I, Kulisevsky, J. Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY. 2023; 29(6)DOI:10.1017/S1355617722000583. PMID:36062534. IF:2.600(Q2/4D).
05/07/2023
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS)
Oteo-Álvaro Á., García C.G., Sánchez A.I., Santamaria C.A., de Diego-Adeliño J.. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10)DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4.200(Q1/3D).
05/07/2023
Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP)
Goodman-Casanova J.M., Cuesta-Lozano D., Alupoaei C., Bello, EMG, Herrera-Imbroda J., Mayoral-Cleries F., Guzman-Parra J.. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:2.600(Q2/3D).
04/07/2023
Available apps for stroke telerehabilitation during corona virus disease 2019 confinement in Spain
Salgueiro C., Urrutia, G, Cabanas-Valdés R.. Available apps for stroke telerehabilitation during corona virus disease 2019 confinement in Spain. Disability and Rehabilitation-Assistive Technology. 2023; 18(5)DOI:10.1080/17483107.2021.1883751. PMID:33576299. IF:1.900(Q2/4D).
04/07/2023
Evaluation of a smoke-free beaches intervention in Barcelona: a quasi-experimental study
Valmayor S., González K., López M.J., Lacera P., Giménez P., Rumín-Caparrós A., Pasarín M.I., Henderson E., Díez E.. Evaluation of a smoke-free beaches intervention in Barcelona: a quasi-experimental study. TOBACCO CONTROL. 2023; DOI:10.1136/tc-2022-057873. PMID:37402576. IF:4.000(Q1/2D).
04/07/2023
Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands
Bruguera, A, Nomah, D, Moreno-Fornis, S, Diaz, Y, Aceiton, J, Reyes-Uruena, J, Ambrosioni, J, Llibre, JM, Falco, V, Imaz, A, Fanjul, F, Navarro, G, Pere, D, Leon, E, Mera, A, Miro, JM, Casabona, J. Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023; 52(4)DOI:10.1093/ije/dyad083. PMID:37403345. IF:6.400(Q1/1D).
03/07/2023
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Kirkham, BW, Egeberg, A, Behrens, F, Pinter, A, Merola, JF, Holzkaemper, T, Gallo, G, Ng, KJ, Bolce, R, Schuster, C, Nash, P, Puig, L. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis. Rheumatology and Therapy. 2023; 10(5)DOI:10.1007/s40744-023-00553-1. PMID:37400681. IF:2.900(Q2/4D).
01/07/2023
The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis
Artola, M, Hernando, A, Vidal, O, Vidal, N, Cuenca, E, Horno, R, Robles, MA, Oriol, C, Peralta, S, Solana, MAJ, Rubio, M, Montero, C, Lleixa, M, Zabay, C, Martin, M, Leon, I, Molinos, C, Matamoros, M, Mercade, L, Fornali, O, Montero, L, Saiz, A, Sola-Valls, N. The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis. JOURNAL OF CLINICAL NURSING. 2023; 32(13-14)DOI:10.1111/jocn.16421. PMID:35799407. IF:3.200(Q1/1D).
01/07/2023
The autoimmune vulnerability of the node of Ranvier
Querol, L, Delmont, E, Lleixa, C. The autoimmune vulnerability of the node of Ranvier. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2023; 28DOI:10.1111/jns.12570. PMID:37272737. IF:4.000(Q1/2D).
01/07/2023
Massive Neonatal Arterial Ischemic Stroke
Arca, G, Nunez, C, Stephan-Otto, C, Arnaez, J, Agut, T, Cordeiro, M, Boronat, N, Lubian-Lopez, S, Benavente-Fernandez, I, Valverde, E, Garcia-Alix, A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3.200(Q1/2D).
01/07/2023
Ischaemic stroke patients present sex differences in gut microbiota
Lledós M., Prats-Sánchez L., Llucià-Carol L., Cárcel-Márquez J., Muino, E, Cullell N., Gallego-Fabrega C., Martín-Campos J.M., Aguilera-Simón A., Guasch-Jiménez M., Guisado-Alonso D., Ramos-Pachón A., Martínez-Domeño A., Izquierdo A., Marín R., Camps-Renom P., Martí-Fàbregas J., Fernández-Cadenas I.. Ischaemic stroke patients present sex differences in gut microbiota. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(11)DOI:10.1111/ene.15931. PMID:37329328. IF:4.500(Q1/2D).
01/07/2023
Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets
Aibar-Duran, JA, Collado, IC, Bejarano, AR, Nevado, RS, Bolanos, IA, Garcia-Cornet, J, Alonso-Solis, A, Bello, EMG, Schmidt, CD, Hernandez, FM, Teixido, JM, Rodriguez, RR. Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets. JOURNAL OF PSYCHIATRIC RESEARCH. 2023; 163DOI:10.1016/j.jpsychires.2023.05.056. PMID:37245316. IF:3.700(Q1/3D).
01/07/2023
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
Hughes, DA, Bichet, DG, Giugliani, R, Hopkin, RJ, Krusinska, E, Nicholls, K, Olivotto, I, Feldt-Rasmussen, U, Sakai, N, Skuban, N, Sunder-Plassmann, G, Torra, R, Wilcox, WR. Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes. JOURNAL OF MEDICAL GENETICS. 2023; 60(7)DOI:10.1136/jmg-2022-108669. PMID:36543533. IF:3.600(Q2/3D).
01/07/2023
Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group (vol 163, pg 29, 2023)
Esteve-Valverde, E, Alijotas-Reig, J, Belizna, C, Marques-Soares, J, Anunciacion-Llunell, A, Feijoo-Masso, C, Saez-Comet, L, Mekinian, A, Ferrer-Oliveras, R, Lefkou, E, Morales-Perez, S, Hoxha, A, Tincani, A, Nalli, C, Pardos-Gea, J, Marozio, L, Maina, A, Espinosa, G, Cervera, R, De Carolis, S, Latino, O, Udry, S, Llurba, E, Garrido-Gimenez, C, Trespidi, L, Gerosa, M, Chighizola, CB, Rovere-Querini, P, Canti, V, Mayer-Pickel, K, Tabacco, S, Arnau, A, Miro-Mur, F. Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group (vol 163, pg 29, 2023). PLACENTA. 2023; 138DOI:10.1016/j.placenta.2023.04.016. PMID:37146536. IF:3.000(Q1/3D).
01/07/2023
Cardiogenic shock code 2023, towards a quality multidisciplinary organization
Martin-Villen, L, Martinez-Selles, M, Diaz, JF, Zapata, L. Cardiogenic shock code 2023, towards a quality multidisciplinary organization. Medicina Intensiva. 2023; 47(7)DOI:10.1016/j.medin.2023.03.006. PMID:37173216. IF:2.700(Q2/4D).
01/07/2023
A critical view on the current use of daptomycin in Spain: The daptomise study
Gonzalez, CGR, de Vega, EC, Martinez, SD, Minero, MV, Urbon, JMG, Manzorro, AG, Martinez, EFD, Sacristan, SC, Santiago, EB, Alonso, AH, de Paredes, PMG, Saez, MS. A critical view on the current use of daptomycin in Spain: The daptomise study. Journal of Infection and Public Health. 2023; 16(7)DOI:10.1016/j.jiph.2023.05.008. PMID:37220712. IF:4.700(Q1/2D).
01/07/2023
PREDICTION OF MULTIDRUG-RESISTANT BACTERIA IN URINARY TRACT INFECTIONS IN THE EMERGENCY DEPARTMENT
Ruiz-Ramos, J, Monje-Lopez, AE, Medina-Catalan, D, Herrera-Mateo, S, Hernandez-Ontiveros, H, Rivera-Martinez, MA, Pereira-Batista, CS, Puig-Campmany, M. PREDICTION OF MULTIDRUG-RESISTANT BACTERIA IN URINARY TRACT INFECTIONS IN THE EMERGENCY DEPARTMENT. JOURNAL OF EMERGENCY MEDICINE. 2023; 65(1)DOI:10.1016/j.jemermed.2023.04.004. PMID:37385920. IF:1.200(Q3/7D).
01/07/2023
Reddish and edematous nodules in an immunosuppressed patient
Mateu-Arrom, L, Rusinol, L, Puig, L. Reddish and edematous nodules in an immunosuppressed patient. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(7)DOI:10.1111/ijd.16512. PMID:36371702. IF:3.500(Q1/3D).
01/07/2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study
Moreno-Arrones, OM, Bea-Ardebol, S, Mayo-Martinez, F, Perez-Pastor, G, Torres-Navarro, I, Bonfill-Orti, M, Deza, G, Ruiz-Salas, V, Masferrer, E, Feal, C, Turrion-Merino, L, Toll, A, Yebenes, M, Galiano-Mejias, S, Jaka, A, Ferrandiz-Pulido, C, Florez, A, Hernandez-Hernandez, N, Fernandez-de-Misa, R, Rios-Buceta, L, Sanmartin, O. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study. Actas Dermo-Sifiliograficas. 2023; 114(7)DOI:10.1016/j.ad.2023.06.011. PMID:37302483. IF:(Q/D).
01/07/2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study.
Moreno-Arrones OM, Béa-Ardebol S, Mayo-Martinez F, Pérez-Pastor G, Torres-Navarro I, Bonfill-Ortí M, Deza G, Ruiz-Salas V, Masferrer E, Feal C, Turrión-Merino L, Toll A, Yébenes M, Galiano-Mejías S, Jaka A, Ferrandiz-Pulido C, Florez A, Hernández-Hernández N, Fernández-de-Misa R, Rios-Buceta L, Sanmartin O. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study.. Actas Dermo-Sifiliograficas. 2023; 114(7)DOI:10.1016/j.ad.2023.04.022. PMID:37088285. IF:(Q/D).
01/07/2023
Life Cycle Assessment of Reusable and Disposable Cystoscopes: A Path to Greener Urological Procedures
Baboudjian M., Pradere B., Martin N., Gondran-Tellier B., Angerri O., Boucheron T., Bastide C., Emiliani E., Misrai V., Breda A., Lechevallier E.. Life Cycle Assessment of Reusable and Disposable Cystoscopes: A Path to Greener Urological Procedures. European Urology Focus. 2023; 9(4)DOI:10.1016/j.euf.2022.12.006. PMID:36543725. IF:4.900(Q1/2D).
01/07/2023
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic
Castellarnau, S, Gaya, JM, Espinosa, J, Sierra, P, Huguet, J, Palou, J, Hernando, D, Sabate, S, Breda, A. Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic. Actas Urologicas Espanolas. 2023; 47(6)DOI:10.1016/j.acuro.2023.01.005. PMID:36776227. IF:1.200(Q3/8D).
01/07/2023
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.
Castellarnau S, Gaya JM, Espinosa J, Sierra P, Huguet J, Palou J, Hernando D, Sabaté S, Breda A. Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.. Actas Urologicas Espanolas. 2023; 47(6)DOI:10.1016/j.acuroe.2023.01.006. PMID:36842706. IF:(Q/D).
01/07/2023
Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study.
Amat-Santos IJ, Delgado-Arana JR, Cruz-González I, Gutiérrez H, García-Bolao I, Millán X, Tirado-Conte G, Ruiz-Nodar JM, Mohandes M, Palazuelos J, Torres Saura F, Del Valle R, Valero Picher E, Núñez García JC, Gómez I, Albarrán Rincón R, Arzamendi D, Nombela-Franco L, Korniiko L, Barrero A, Santos-Martínez S, Serrador A, San Román JA. Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study.. REVISTA ESPANOLA DE CARDIOLOGIA. 2023; 76(7)DOI:10.1016/j.rec.2022.08.001. PMID:35934294. IF:(Q/D).